Recent Quotes

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Comirnaty (COVID-19 vaccine) is its first commercialized product.

Earnings

Q1 2021		Est.		Actual		Surprise
EPS		3.720		5.290		1.5700
REV		1.780B		2.470B		690.000M

Q4 2020		Est.		Actual		Surprise
EPS		-0.180		1.870		2.0500
REV		224.870M		411.870M		187.000M

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
BNTX	BioNTech	232.78	3.28	1.43%		55.4B

BioNTech Frequently Asked Questions

How do I buy BioNTech (BNTX) stock?

You can purchase shares of BioNTech (NASDAQ: BNTX) through any online brokerage.

View our list of the best stock brokerages.

Who are BioNTech's (BNTX) competitors?

Other companies in BioNTech’s space includes: Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Amgen (NASDAQ:AMGN), Natera (NASDAQ:NTRA) and Arrowhead Pharmaceuticals (NASDAQ:ARWR).

What is the target price for BioNTech (BNTX) stock?

The latest price target for BioNTech (NASDAQ: BNTX) was reported by Redburn Partners on June 16, 2021. The analyst firm set a price target for 0.00 expecting BNTX to fall to within 12 months (a possible -100.00% downside). 24 analyst firms have reported ratings in the last year.

Current Stock Price for BioNTech (BNTX)?

The stock price for BioNTech (NASDAQ: BNTX) is $229.5 last updated Wed Jun 23 2021 20:00:04 GMT+0000 (Coordinated Universal Time).

Does BioNTech (BNTX) pay a dividend?

There are no upcoming dividends for BioNTech.

When is BioNTech (NASDAQ:BNTX) reporting earnings?

BioNTech’s Q2 earnings are confirmed for after-market on August 10, 2021.

Is BioNTech (BNTX) going to split?

There is no upcoming split for BioNTech.

What sector and industry does BioNTech (BNTX) operate in?

BioNTech is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.